BioCentury
ARTICLE | Clinical News

IntraDose: Completed Phase II study enrollment

August 16, 1999 7:00 AM UTC

IntraDose also is in Phase II testing to treat primary liver cancer and Phase III testing to treat head and neck cancer. ...